HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesca Biagioni Selected Research

High-Temperature Requirement A Serine Peptidase 2

1/2018Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson's Disease.
1/2018Erratum to "Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson's Disease".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesca Biagioni Research Topics

Disease

19Neoplasms (Cancer)
03/2022 - 06/2010
16Parkinson Disease (Parkinson's Disease)
04/2021 - 04/2005
9Breast Neoplasms (Breast Cancer)
01/2018 - 05/2012
8Glioblastoma (Glioblastoma Multiforme)
03/2022 - 02/2013
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 05/2005
7Parkinsonian Disorders (Parkinsonism)
04/2021 - 01/2004
5Carcinogenesis
03/2022 - 06/2010
5Alzheimer Disease (Alzheimer's Disease)
01/2019 - 03/2008
4Status Epilepticus (Complex Partial Status Epilepticus)
03/2022 - 06/2008
4Seizures (Absence Seizure)
03/2022 - 04/2007
4Inflammation (Inflammations)
10/2020 - 01/2016
3Synucleinopathies
03/2022 - 05/2005
3Movement Disorders (Movement Disorder)
10/2021 - 04/2005
3Brain Ischemia (Cerebral Ischemia)
06/2021 - 03/2005
3Muscular Atrophy (Muscle Atrophy)
01/2021 - 12/2017
3Neuroinflammatory Diseases
11/2020 - 11/2019
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2020 - 07/2012
3Mental Disorders (Mental Disorder)
03/2020 - 01/2018
3Brain Neoplasms (Brain Tumor)
01/2020 - 06/2010
3Disease Progression
12/2017 - 01/2009
3Epilepsy (Aura)
06/2015 - 09/2004
3Neoplasm Metastasis (Metastasis)
03/2015 - 08/2014
3Motor Neuron Disease (Primary Lateral Sclerosis)
01/2014 - 07/2012
2Adenocarcinoma
03/2022 - 11/2021
2Infarction (Infarctions)
06/2021 - 02/2009
2Nervous System Diseases (Neurological Disorders)
04/2020 - 01/2017
2Gliosis
11/2019 - 03/2008
2Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2019 - 12/2013
2Huntington Disease (Huntington's Disease)
12/2013 - 01/2007
2Ischemia
02/2009 - 12/2008
2Temporal Lobe Epilepsy
12/2008 - 04/2007
1Scrapie
01/2021
1Neuromuscular Diseases (Neuromuscular Disease)
01/2021
1Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease)
01/2021
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2021
1Disseminated Intravascular Coagulation
11/2020
1Virus Diseases (Viral Diseases)
11/2020
1COVID-19
11/2020
1Infections
11/2020
1Multiple Organ Failure (MODS)
11/2020
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
10/2020
1Liver Neoplasms (Liver Cancer)
10/2020
1Hepatocellular Carcinoma (Hepatoma)
10/2020
1Macular Degeneration (Age-Related Maculopathy)
08/2020
1Osteoporosis
08/2020

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
03/2022 - 03/2005
10Dopamine (Intropin)FDA LinkGeneric
10/2021 - 05/2005
9alpha-SynucleinIBA
03/2022 - 05/2005
9MicroRNAs (MicroRNA)IBA
01/2018 - 06/2010
7Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2014
5Sirolimus (Rapamycin)FDA Link
01/2022 - 02/2013
5Proteasome Endopeptidase Complex (Proteasome)IBA
11/2020 - 04/2005
4NeurotoxinsIBA
04/2021 - 06/2008
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2021 - 01/2004
4PhytochemicalsIBA
11/2020 - 07/2019
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2020 - 06/2010
3Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2022 - 09/2004
3Prion ProteinsIBA
11/2021 - 10/2019
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 01/2009
3Neuroprotective AgentsIBA
10/2020 - 01/2017
3UbiquitinIBA
06/2020 - 04/2005
3TOR Serine-Threonine KinasesIBA
04/2020 - 06/2012
3LithiumIBA
01/2019 - 01/2014
2SynucleinsIBA
03/2022 - 12/2013
2GoldIBA
03/2022 - 11/2021
2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2022 - 09/2004
2BicucullineIBA
03/2022 - 06/2008
2Methamphetamine (Desoxyn)FDA LinkGeneric
01/2021 - 01/2018
2Pattern Recognition ReceptorsIBA
11/2020 - 01/2016
2PolyphenolsIBA
11/2020 - 10/2020
2Amyloid beta-PeptidesIBA
04/2020 - 12/2008
2tau Proteins (tau Protein)IBA
01/2020 - 03/2008
2Levodopa (L Dopa)FDA LinkGeneric
01/2018 - 01/2009
2High-Temperature Requirement A Serine Peptidase 2IBA
01/2018 - 01/2018
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 12/2013
2Epidermal Growth Factor (EGF)IBA
03/2015 - 06/2010
2Estrogen ReceptorsIBA
01/2015 - 08/2014
2Protein Isoforms (Isoforms)IBA
11/2014 - 01/2007
2Metformin (Glucophage)FDA LinkGeneric
06/2014 - 05/2012
2ErbB Receptors (EGF Receptor)IBA
03/2014 - 06/2010
2PlasticsIBA
01/2014 - 12/2013
2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2013 - 01/2004
2Kainic Acid (Kainate)IBA
12/2008 - 04/2007
1Peroxidase (Myeloperoxidase)IBA
03/2022
1Endopeptidase K (Proteinase K)IBA
03/2022
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1AMPA Receptors (AMPA Receptor)IBA
01/2022
1Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2021
1Coloring Agents (Dyes)IBA
06/2021
1CytokinesIBA
11/2020
1Dacarbazine (DIC)FDA LinkGeneric
11/2020
1FlavonoidsIBA
11/2020
1CurcuminIBA
10/2020
1Cre recombinaseIBA
10/2020
1CateninsIBA
10/2020
1Bone Morphogenetic Protein 2IBA
08/2020
1Androgen Receptors (Androgen Receptor)IBA
06/2020

Therapy/Procedure

8Therapeutics
11/2020 - 08/2006
2Denervation
01/2021 - 08/2006
1Adjuvant Chemotherapy
11/2021